Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

Status Withdrawn

Clinical Trial Summary

The aim of this study is to compare the clinical effectiveness of intravenous esomeprazole and pantoprazole in preventing recurrent bleeding in the patients with high-risk bleeding peptic ulcers after successful standard endoscopic hemostasis.

Clinical Trial Description

Endoscopic hemostasis and proton pump inhibitor (PPI) constitute the cornerstone in the management of peptic ulcer bleeding (PUB), which remains a prevalent disorder associated with substantial morbidity and mortality. Clinical effectiveness of PPI in the management of patients with PUB has been established by compelling evidence derived from a number of randomized trials. However, whether different PPIs are equally effective has not been investigated. Esomeprazole, the S-isomer of omeprazole, may achieve faster, more profound and steady acid suppression than other PPIs, but it remains undetermined whether the superiority of pharmacologic efficacy may be translated into advantages in clinical outcomes. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00881413
Study type	Interventional
Source	Lotung Poh-Ai Hospital
Contact
Status	Withdrawn
Phase	Phase 4

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00471029` - Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer	Phase 4
Completed	`NCT00152399` - Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding	Phase 2
Not yet recruiting	`NCT02961296` - Helicobacter Pylori Antibiotic Susceptibility Testing of Korea	N/A
Completed	`NCT00212225` - Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)	N/A
Completed	`NCT02342470` - Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users	Phase 2
Completed	`NCT02296021` - Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy	Phase 4
Completed	`NCT00977678` - Drop in Gastroscopy - Experience After 9 Months	N/A
Terminated	`NCT04025983` - Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection	N/A
Recruiting	`NCT03868267` - Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting
Completed	`NCT05237115` - Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy	Phase 4
Completed	`NCT01667718` - Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment	Phase 4
Not yet recruiting	`NCT04784910` - Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer	Phase 3
Recruiting	`NCT02436018` - WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy	N/A
Completed	`NCT03367897` - Bleeding Ulcer and Erosions Study "BLUE Study"
Active, not recruiting	`NCT02001727` - HEP-FYN 12-Years Follow-up	N/A
Completed	`NCT01376414` - H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department	N/A
Completed	`NCT01667692` - Aizthromycin or Clarithromycin in H-pylori Eradication Regimen	Phase 4
Completed	`NCT01080326` - Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus	N/A
Completed	`NCT02536989` - Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot	Phase 4
Completed	`NCT00920400` - Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract	N/A